| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| HILIC NEGATIVE ION MODE | glucuronate | 0.2006 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 0.2261 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.2782 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.3475 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.3658 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.3661 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 0.3730 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 0.3782 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.3992 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.4659 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.4730 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 0.4744 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.4971 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.5007 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.5149 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.5173 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.5500 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.5545 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.5573 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 0.5628 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.5728 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.5767 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.5784 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 0.6007 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.6081 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.6145 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.6170 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 0.6318 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.6397 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.6491 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.6495 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.6916 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 0.6933 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.6964 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.7241 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.7246 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.7345 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.7432 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.7491 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 0.7609 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.7713 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 0.7766 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.7793 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.7817 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 0.7819 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 0.7820 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.7895 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.7909 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.7912 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.7944 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 0.7975 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.7982 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.8045 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.8309 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.8356 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.8418 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 0.8425 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.8496 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.8499 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.8570 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.8597 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 0.8693 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.8737 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.8751 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.8787 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 0.8792 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 0.8903 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9020 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9089 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9128 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9136 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9169 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9172 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9302 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9312 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9377 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9380 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9385 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9406 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9420 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9450 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9495 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9527 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9575 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9597 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9679 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9832 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9870 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9930 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9934 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9966 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9977 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 0.9980 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 1.0000 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 1.0020 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.0023 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.0074 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 1.0104 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.0173 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.0185 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.0234 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.0291 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 1.0321 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.0346 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.0571 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 1.0626 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.0660 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.0678 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.0765 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 1.0840 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.0891 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.0918 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.0951 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 1.0963 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 1.1012 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 1.1078 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 1.1104 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.1333 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.1358 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.1448 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.1510 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.1526 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 1.1611 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 1.1731 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.1735 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.1759 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 1.1835 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.1861 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.1896 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.1900 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.1920 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.1956 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.2021 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.2090 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.2104 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 1.2104 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.2141 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.2164 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 1.2279 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.2308 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.2311 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.2311 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.2411 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.2417 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.2432 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.2459 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 1.2491 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 1.2508 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.2571 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.2815 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.2838 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.3226 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 1.3261 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.3307 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.3344 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.3384 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 1.3438 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 1.3775 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.3804 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 1.3807 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.3866 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.4290 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.4307 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.4383 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.4656 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.4691 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 1.4869 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 1.4938 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.5301 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 1.5492 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.5640 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 1.5805 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 1.5856 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 1.6115 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 1.6227 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.6260 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.7043 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.7428 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 1.7752 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | glucuronate | 1.7846 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.7853 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.7866 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | glucuronate | 1.8622 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 1.9042 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 2.1710 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 2.3840 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | glucuronate | 3.9336 | scaled units | Placebo | -0.5HR |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|